Lycopodium Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Lycopodium ha aumentado sus beneficios a una tasa media anual de 33.8%, mientras que los beneficios de la industria de Construction han experimentado un crecimiento de 24.8% anual. Los ingresos han ido creciendo a una tasa media de 17.2% al año. La rentabilidad financiera de Lycopodium es de 40%, y sus márgenes netos son de 14.7%.

Información clave

33.8%

Tasa de crecimiento de los beneficios

33.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Construction	15.2%
Tasa de crecimiento de los ingresos	17.2%
Rentabilidad financiera	40.0%
Margen neto	14.7%
Última actualización de beneficios	30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Lycopodium. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

CHIA:LYL Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	345	51	2
31 Mar 24	343	54	2
31 Dec 23	341	57	2
30 Sep 23	332	52	2
30 Jun 23	324	47	2
31 Mar 23	305	39	2
31 Dec 22	286	32	2
30 Sep 22	257	29	2
30 Jun 22	229	27	2
31 Mar 22	209	25	2
31 Dec 21	190	23	2
30 Sep 21	174	19	2
30 Jun 21	158	14	2
31 Mar 21	164	12	2
31 Dec 20	170	9	2
30 Sep 20	190	10	1
30 Jun 20	209	12	1
31 Mar 20	199	14	3
31 Dec 19	190	17	5
30 Sep 19	171	17	6
30 Jun 19	152	17	8
31 Mar 19	163	18	8
31 Dec 18	173	20	8
30 Sep 18	183	19	8
30 Jun 18	193	18	9
31 Mar 18	199	15	9
31 Dec 17	206	12	8
30 Sep 17	211	11	8
30 Jun 17	217	10	8
31 Mar 17	191	9	8
31 Dec 16	165	8	8
30 Sep 16	145	6	8
30 Jun 16	124	3	8
31 Mar 16	124	1	8
31 Dec 15	124	-2	8
30 Sep 15	123	-1	8
30 Jun 15	123	-1	8
31 Mar 15	121	-1	8
31 Dec 14	119	-1	8
30 Sep 14	137	2	8
30 Jun 14	155	4	8
31 Mar 14	187	10	5
31 Dec 13	218	16	2

Ingresos de calidad: LYL tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio (14.7%) de LYL son superiores a los del año pasado (14.4%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lLYL han crecido significativamente en un 33.8% al año.

Acelerando crecimiento: El crecimiento de los beneficios de LYL en el último año (8.4%) está por debajo de su media de 5 años (33.8% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de LYL en el último año (8.4%) no superó al de la industria Construction 16.2%.

Lycopodium Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Lycopodium Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

First half 2024 earnings released: EPS: AU$0.75 (vs AU$0.50 in 1H 2023)

Lycopodium Limited to Report First Half, 2024 Results on Feb 21, 2024

Full year 2023 earnings released: EPS: AU$1.18 (vs AU$0.68 in FY 2022)

Lycopodium Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

First half 2023 earnings released: EPS: AU$0.50 (vs AU$0.38 in 1H 2022)

Recent updates

Lycopodium Limited (ASX:LYL) entered into a Heads of Agreement to acquire 60% stake in Saxum Ingenieria S.a.

Lycopodium Limited, Annual General Meeting, Nov 12, 2024

Upcoming dividend of AU$0.40 per share

Independent Non-Executive Director recently bought AU$98k worth of stock

Lycopodium Limited Approves A Fully Franked Final Dividend for the Six Months Ended June 30, 2024, Payable on 4 October 2024

Final dividend of AU$0.40 announced

Now 28% undervalued

Lycopodium Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 25% undervalued

Now 20% undervalued after recent price drop

Now 20% undervalued

Executive Director recently sold AU$17m worth of stock

Upcoming dividend of AU$0.37 per share

Now 20% undervalued

MD & Executive Director recently sold AU$643k worth of stock

First half dividend of AU$0.37 announced

First half 2024 earnings released: EPS: AU$0.75 (vs AU$0.50 in 1H 2023)

Lycopodium Limited to Report First Half, 2024 Results on Feb 21, 2024

Executive Director recently sold AU$162k worth of stock

Upcoming dividend of AU$0.45 per share at 8.9% yield

Lycopodium Limited Announces Franked Dividend for the Six Months Ended 30 June 2023, Payable on 6 October 2023

Lycopodium Limited, Annual General Meeting, Nov 14, 2023

Full year 2023 earnings released: EPS: AU$1.18 (vs AU$0.68 in FY 2022)

Lycopodium Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Non-Executive Director recently sold AU$1.0m worth of stock

Investor sentiment improves as stock rises 16%

Upcoming dividend of AU$0.36 per share at 9.0% yield

First half 2023 earnings released: EPS: AU$0.50 (vs AU$0.38 in 1H 2022)

Lycopodium Limited to Report First Half, 2023 Results on Feb 22, 2023

Less than half of directors are independent

Upcoming dividend of AU$0.36 per share

Executive Director recently sold AU$329k worth of stock

Full year 2022 earnings released: EPS: AU$0.68 (vs AU$0.36 in FY 2021)

Lycopodium Limited to Report Fiscal Year 2022 Final Results on Oct 11, 2022

Lycopodium Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Lycopodium Limited Appoints Louise Bower as Non-Executive Director

Lycopodium Limited Announces the Resignation of Robert Osmetti as Director

Now 23% undervalued after recent price drop

Non-Executive Director recently sold AU$450k worth of stock

Lycopodium Limited Updates Earnings Guidance for the Year Ending 30 June, 2022

Less than half of directors are independent

Lycopodium Limited Announces Resignation of Lawrence (Laurie) Marshall as Director

Now 21% undervalued

Upcoming dividend of AU$0.18 per share

Now 22% undervalued

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Lycopodium Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 7, 2022

Lycopodium Limited to Report First Half, 2022 Results on Feb 23, 2022

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.30 in FY 2020)

Less than half of directors are independent

First half 2021 earnings released: EPS AU$0.15 (vs AU$0.23 in 1H 2020)

New 90-day high: AU$5.89

New 90-day high: AU$5.05

New 90-day high: AU$4.87

Lycopodium Limited Wins EP Contract for Sandfire's Motheo Contract

Market bids up stock over the past week

Lycopodium Limited Announces Appointment of Karl Cicanese as its Director

Non-Executive Director recently sold AU$390k worth of stock

Earnings released

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado